View of Early Isolated Central Nervous System Relapse of Mantle Cell Lymphoma Successfully Treated with Ibrutinib and Chimeric Antigen Receptor T-Cell Therapy – A Case Report

Return to Issue Details Early Isolated Central Nervous System Relapse of Mantle Cell Lymphoma Successfully Treated with Ibrutinib and Chimeric Antigen Receptor T-Cell Therapy – A Case Report Download Download PDF